Publication | Open Access
Early and sustained efficacy of fremanezumab over 24-weeks in migraine patients with multiple preventive treatment failures: the multicenter, prospective, real-life FRIEND2 study
58
Citations
25
References
2023
Year
| Year | Citations | |
|---|---|---|
Page 1
Page 1